Twist Bioscience Corp (TWST) Operating Income (Loss) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Twist Bioscience Corp quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • Twist Bioscience Corp Operating Income (Loss) for the quarter ending March 31, 2024 was -$48.9 M, a 20.7% increase year-over-year.
  • Twist Bioscience Corp Operating Income (Loss) for the twelve months ending March 31, 2024 was -$207 M, a 7.82% increase year-over-year.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2023 was -$217 M, a 7.5% increase from 2022.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2022 was -$235 M, a 53.7% decline from 2021.
  • Twist Bioscience Corp annual Operating Income (Loss) for 2021 was -$153 M, a 9.03% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$207 M -$48.9 M +$12.7 M +20.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$220 M -$47 M -$2.35 M -5.26% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 -$217 M -$50.1 M +$6.76 M +11.9% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-21
Q2 2023 -$224 M -$60.8 M +$382 K +0.63% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$224 M -$61.6 M -$835 K -1.37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$223 M -$44.6 M +$11.3 M +20.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 -$235 M -$56.9 M -$17.1 M -42.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-21
Q2 2022 -$218 M -$61.2 M -$19 M -45.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$199 M -$60.8 M -$22.8 M -60% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$176 M -$55.9 M -$23.1 M -70.6% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 -$153 M -$39.8 M -$15.8 M -66.1% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 -$137 M -$42.1 M -$13.9 M -49.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$123 M -$38 M -$5.92 M -18.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$117 M -$32.8 M +$23 M +41.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 -$140 M -$24 M +$7.6 M +24.1% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 -$148 M -$28.2 M -$75 K -0.27% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$148 M -$32.1 M -$5.82 M -22.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$142 M -$55.8 M -$32.9 M -144% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$109 M -$31.6 M -$11.9 M -60.2% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 -$97 M -$28.1 M -$10.6 M -60.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$86.4 M -$26.3 M -$9.65 M -58% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$76.7 M -$22.9 M -$6.15 M -36.7% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$70.6 M -$19.7 M Jul 1, 2018 Sep 30, 2018 10-K 2020-11-27
Q2 2018 -$17.5 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$16.6 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$16.8 M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.